NHS: Drugs

(asked on 3rd July 2018) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of any potential risks to the supply of medicines to patients in the event that the UK leaves the EU without an agreement.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 6th July 2018

Patient safety is paramount in our exit negotiations and maintaining continuity of supply of all medicines and medical isotopes is a key part of ensuring patients continue to receive the safe, high-quality care they need from day one of European Union exit and thereafter.

Extensive work has been undertaken to understand the implications of our exit on the National Health Service, considering a range of negotiation outcomes, including exit without a withdrawal agreement. This has included a particular focus on continued access to medicines.

Reticulating Splines